Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 April 2019 | Story Valentino Ndaba | Photo Valentino Ndaba
William Kandowe, principal of the Albert Street School in Johannesburg, Dr Faith Mkwananzi, the author, and DR Chris High
From right: William Kandowe, principal of the Albert Street School in Johannesburg, Dr Faith Mkwananzi, the author, and DR Chris High, Senior Lecturer at Linnaeus University in Sweden, at the book launch.

Dr Faith Mkwananzi’s road from secondary school to university has been paved with challenges. After repeating her matric five times in Zimbabwe, she became an international university student in South Africa in 2006. Some years later, on 3 April 2019, the University of the Free State’s (UFS) Bloemfontein Campus witnessed the launch of her excellent book titled: Higher Education, Youth and Migration in Contexts of Disadvantages: Understanding Aspirations and Capabilities, which was informed by these and many circumstances.

Aspirations formation

The book speaks to her own life. “Born and raised in Zimbabwe in KwaBulawayo, I had my own aspirations. I knew I did not want be a nurse   my mother’s earnest interest and desire for me,” said Dr Mkwananzi as she related the fluid dreams her seven-year-old self had that culminated into aspirations to enter academia.

Aspirations enabled Dr Mkwananzi’s capabilities to pursue a PhD in Development Studies at UFS, and then write her book. “Higher education aspirations are worth pursuing,” said the current postdoctoral researcher at the university’s South African Research Chair Initiative (SARChI) in Higher Education and Human Development Research Programme, as she reflected on her academic journey.

Voices of marginalised migrants
 

Dr Mkwananzi has focused her book on the lives, experiences and the formation of higher education aspirations among marginalised migrant youth in Johannesburg. She gives these young people a voice to narrate their own story, making this research an essential work for understanding the conditions necessary for youth to live valuable lives in both local and international contexts. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept